Slides
Page 1
ROSSARI BIOTECH LIMITED Q2FY27 Investor Presentation
Page 2
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Rossari Biotech Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. This presentation contains certain forward looking statements concerning the Company’s future business prospects and business profitability, which are subject to a number of risks and uncertainties and the actual results could materially differ from those in such forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, competition (both domestic and international), economic growth in India and abroad, ability to attract and retain highly skilled professionals, time and cost over runs on contracts, our ability to manage our international operations, government policies and actions regulations, interest and other fiscal costs generally prevailing in the economy. The Company does not undertake to make any announcement in case any of these forward looking statements become materially incorrect in future or update any forward looking statements made from time to time by or on behalf of the Company. 2
Page 3
Q2FY27 Performance Highlights
Page 4
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Management Commentary 4 Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said We delivered robust consolidated growth of 19% YoY in Q2FY27, achieving a record quarterly revenue of Rs. 698 crores. The performance was driven by healthy momentum in the domestic business and the continued expansion of our international presence. We concluded the first half of FY27 on a strong note, with consolidated revenue of Rs. 1,395 crores in H1FY27, a healthy growth of 23% YoY. The growth was broad-based, led by healthy volume, improved product mix and focused execution across our businesses. During Q2FY27, the HPPC, TSC and AHN businesses delivered YoY growth of 18%, 26% and 11%, respectively. Performance was supported by a higher contribution from value-added products and improved wallet share with customers across end-user industries. We continue to operate under dynamic business environment marked by raw material volatility, geopolitical uncertainty and cautious customer behaviour. Despite of these headwinds in Q2FY27 we maintained the gross margin at ~32% level and EBITDA margin at ~12.5% level. During H1FY27, we made progress in strengthening our balance sheet and improving cash flow generation. Our net working capital cycle improved to 86 days as of 30 September 2026, compared with 97 days as of 31 March 2026. Further, net debt declined to Rs. 221 crores from Rs. 281 crores over the same period. We are pleased to announce that the Board has approved the leasing of land to Rossari International Limited Company (RILC), our wholly owned subsidiary, for setting up a greenfield manufacturing facility in the Kingdom of Saudi Arabia (KSA). This builds on the in-principle approval granted by the Board earlier and marks a key milestone in Rossari’s international growth journey. Our strategic initiatives are progressing in the right direction. These include monetising non-core assets, rationalising lower-margin businesses and improving the product mix. We remain confident that operating leverage, scale benefits and these initiatives will support progressive improvement in profitability. With strong R&D capabilities, expanding capacities, a healthy balance sheet and a growing global footprint, we are well placed to build an integrated, intelligent and impactful specialty chemicals platform and deliver sustained long-term growth.
Page 5
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Q2FY27 – Key Business Updates 5 Kingdom of Saudi Arabia (KSA) Facility • The Board has approved the leasing of land by Rossari International Limited Company, a wholly owned subsidiary, for setting up a greenfield manufacturing facility in the Kingdom of Saudi Arabia (KSA) Financial Highlights – Q2FY27 • Highest-ever quarterly revenue of Rs. 697.6 crores, a 19.0% growth on y- o-y basis • Highest-ever quarterly EBITDA of Rs. 87.0 crores, a 20.9% growth on y-o-y basis • Profit After Tax stood at Rs. 38.9 crores, remained subdued due to higher depreciation arising from investments in long-term projects • Highest-ever export sales of Rs. 216.4 crores, a 33.8% growth on y-o-y basis • Strong Cash flow from Operations at Rs. 131 crores • Net working capital improved to 86 days as of September 2026 from 97 days as of March 2026. • Net debt declined to Rs. 221 crores from Rs. 281 crores as of March 2026 Home, Personal Care and Performance Chemicals • Successfully completed the Stage 1 EXCiPACT audit for Pharma business • Strategically expanding our preservative and mild surfactant portfolio • Agro business in general was sluggish because of El Niño • Commissioned one of India’s largest EO storage facility at our Unitop site Textile Specialty Chemicals • New geographies added - Peru and Indonesia • New products introduced - o Yarn and thread lubricants portfolio expanded o Spin-finish for Fully Drawn Yarn (FDY) o New product category for denim processing Animal Health and Nutrition • New range of disinfectants introduced • Emulsifiers for poultry feed as new product category • Liquid enzymes for exports • Biosurfactant based gut health modulator for poultry
Page 6
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Key Financial Highlights 6 Gross Profit 185.2 220.3 357.6 426.7 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 +19% +19% EBITDA 71.9 87.0 139.8 167.6 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 +21% +20% Profit After Tax 36.9 38.9 70.5 74.0 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 +6% +5% (INR in crores)Total Revenue 586.1 697.6 1,129.8 1,394.8 Q2FY26 Q2FY27 H1FY26 H1FY27 +19% +23% 31.6% 31.6% Margin31.7% 30.6% 6.3% 5.6%12.3% 12.5% 12.4% 12.0% Margin6.2% 5.3%
Page 7
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Q2FY27 Operating Performance 7 TSC - Textile Specialty Chemicals 95.8 120.8 183.1 226.9 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 +26% +24% AHN – Animal Health & Nutrition 31.4 34.8 61.4 72.8 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 +11% +19% Geographical Revenue (INR in crores) HPPC – Home, Personal Care and Performance Chemicals 458.9 542.0 885.3 1,095.1 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 +18% +24% 28% 72% Q2FY26 31% 69% Q2FY27 27% 73% H1 FY26 27% 73% H1 FY27 Export Domestic • Figures for previous periods have been reclassified, wherever necessary, to align with the classification adopted for the current period.
Page 8
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Performance excluding Institutional and B2C 8 EBITDA 75.7 87.2 150.3 171.3 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 +15% +14% (INR in crores) 511.0 619.9 984.4 1,246.2 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 +21% +27% • Our core business continued to deliver strong YoY growth, driven by B2B business expertise, diversified product portfolio and deep customer engagement across markets • Excluding Institutional and B2C businesses, EBITDA margin in Q2 FY27 stood at 14.1%, reflecting the underlying strength and stability of the core B2B business 14.8% 14.1% Margin15.3% 13.8% Revenue • Institutional Business and B2C Business refers to sales of Wholly Owned Subsidiaries, Buzil Rossari (Rossari Professional) and Rossari Consumer Products respectively.
Page 9
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Institutional and B2C Performance 9 (INR in crores) Revenue -5.2% Margin • Revenue from Institutional & B2C business remained flat on a YoY basis; however, profitability improved significantly, resulting in notable improvement in EBITDA • Continued focus on portfolio rationalization and improving the quality of revenues across these segments 0.2% Revenue 75.1 77.7 145.4 148.6 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 +3% +2% -3.9 0.2 -10.6 -3.7 Q2 FY26 Q2 FY27 H1 FY26 H1 FY27 -7.3% -2.5% EBITDA • Institutional Business and B2C Business refers to sales of Wholly Owned Subsidiaries, Buzil Rossari (Rossari Professional) and Rossari Consumer Products respectively.
Page 10
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Particulars (INR in crores) Q2FY27 Q2FY26 YoY% H1FY27 H1FY26 YoY% Revenues from Operations 697.6 586.1 19.0% 1,394.8 1,129.8 23.5% Cost of Goods Sold 477.3 400.9 968.1 772.2 Gross Profit 220.3 185.2 18.9% 426.7 357.6 19.3% Gross Profit Margin (%) 31.6% 31.6% 30.6% 31.7% Employee expense 43.6 37.8 87.7 75.3 Other expenses 89.7 75.5 171.4 142.6 EBITDA 87.0 71.9 21.0% 167.6 139.7 20.0% EBITDA Margin (%) 12.5% 12.3% 12.0% 12.4% Other Income 0.6 1.6 3.8 2.8 Depreciation and Amortization 30.1 18.2 55.7 36.0 EBIT 57.5 55.3 115.7 106.6 EBIT Margin (%) 8.2% 9.4% 8.3% 9.4% Finance Costs 8.7 6.1 19.7 11.8 Share of profit of joint venture and associate 0.5 0.5 0.9 1.0 PBT 49.3 49.7 96.9 95.8 Tax expense 10.4 12.8 22.9 25.3 PAT 38.9 36.9 5.4% 74.0 70.5 5.0% PAT Margin (%) 5.6% 6.3% 5.3% 6.2% EPS Diluted (Rs.)* 7.02 6.65 13.36 12.74 Consolidated Profit & Loss Statement 10 *Not Annualised
Page 11
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Consolidated Balance Sheet 11 ASSETS (INR in crores) Sep-26 Mar-26 Non-current Assets 1,058.8 1,045.1 Property, plant and equipment 510.7 466.5 Right of Use Assets 91.7 94.0 Capital Work-in-progress 156.2 173.3 Goodwill 118.7 118.7 Other Intangible Assets 95.8 105.2 Investments accounted using equity method 27.9 27.0 Financial Assets (i) Investments 0.0* 0.2 (ii) Other Financial Assets 9.7 8.9 Income Tax Assets (Net) 11.9 12.0 Deferred Tax Assets (Net) 17.3 14.9 Other Non-current Assets 18.9 24.4 Current Assets 1,300.6 1,235.9 Inventories 444.0 404.5 Financial Assets (i) Investments 30.0 35.1 (ii) Trade Receivables 553.7 557.4 (iii) Cash and cash Equivalents 84.4 75.3 (iv) Bank balances other than cash 26.4 16.9 (v) Loans 1.0 1.2 (vi) Other Financial Assets 6.4 5.9 Other Current Assets 154.8 139.6 Non current assets held for sale - 7.8 Total Assets 2,359.5 2,288.8 EQUITY & LIABILITIES (INR in crores) Sep-26 Mar-26 Equity 1,407.6 1,333.3 Equity Share Capital 11.1 11.1 Other Equity 1,396.5 1,322.2 Non-Current Liabilities 149.0 165.9 Financial Liabilities (i) Borrowings 82.1 94.3 (ii) Lease Liabilities 17.2 20.3 Provisions 9.5 8.3 Deferred Tax Liabilities (Net) 40.2 43.0 Current Liabilities 802.9 789.6 Financial Liabilities (i) Borrowings 279.7 313.7 (ii) Lease Liabilities 9.1 7.7 (iii) Trade Payables 343.6 323.5 (iv) Other Financial Liabilities 123.9 116.0 Other Current Liabilities 26.0 11.4 Provisions 8.8 8.3 Current Tax Liabilities (Net) 11.8 9.0 Total Equity & Liabilities 2,359.5 2,288.8 *Below rounding off norms
Page 12
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Consolidated Cash Flow Statement 12 Particulars (INR in crores) Sep-26 Sep-25 Net Profit before Tax 96.9 95.8 Adjustments for: Non-Cash Items/ Other Investment or Financial Items 76.1 42.5 Operating Profit before working capital changes 173.0 138.3 Changes in Working Capital -16.1 -132.2 Cash generated from Operations 156.9 6.1 Direct taxes paid (net of refund)* -25.5 -31.1 Net Cash from Operating Activities 131.4 -25.0 Net Cash from Investing Activities -49.5 -106.3 Net Cash from Financing Activities -72.4 121.6 Net Decrease in Cash and Cash Equivalents 9.5 -9.7 Net Foreign exchange difference on translation of foreign operations -0.4 1.0 Add: Cash & Cash equivalents at the beginning of the period 75.3 44.2 Cash & Cash equivalents at the end of the period 84.4 35.5
Page 13
Company Overview
Page 14
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Rossari – A Surfactant and Ethoxylation-led Specialty Chemical Company 14 29+ Years of Experience 4 R&D Centres 80+ Countries Served 8 Manufacturing Facilities 387,100 MTPA Capacity Rossari is a Specialty-Chemical manufacturer Expertise in Ethoxylation (surfactant chemistry), Silicone chemistry, and Polymer chemistry, providing intelligent and sustainable chemical solutions for customers across industries. 3,000+ Products Portfolio Tailored solutions for diverse customer needs 25% Revenue CAGR % (FY19-26) Consistent and profitable growth 2,300+ Customers across diverse end use industries Top 10 customer concentration < 15% 18% Long-term value creation PAT CAGR % (FY19-26) 77% 17% HPPC TSC 6% AHN FY26 Revenue Rs. 2,396 crores 74% 26% Domestic Export
Page 15
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials • Launched HPPC Division • Established a representative office to cater to textile division in Dhaka, Bangladesh • Formed a JV with Buzil Werk Wagner • Acquired 13 acres of land at Dahej GIDC (Bharuch, Gujarat) • Supplies to leading washing machine and dish washer manufacturers for laundry detergents and dishwasher liquids • Acquired Lozalo International, a leading veterinary cosmetics brand, to expand Pet Care portfolio • Crossed the turnover of Rs. 500 crores 29+ Years Journey of Transformation 15 • Acquired Unitop Chemicals, a manufacturer of surfactants and specialty chemicals • Acquired Tristar Intermediates and its high-tech distillation manufacturing facilities • Made the strategic investment in Romakk Chemicals • Acquired defoamer business of Trio Chemicals and Allied Products • 1997: Founded by Edward Menezes and Sunil Chari as a small venture • Incorporated as a partnership firm named Rossari Labtech in 2003 • Acquired 10 acres of strategically located land in Silvassa, India. • Established a large-scale manufacturing facility at Silvassa • Converted into a Joint Stock Company as Rossari Biotech Limited • Diversified into Animal Health and Nutrition (AHN) and Construction Chemicals • Approved its textile auxiliaries’ range by the Global Organic Textile Standards • Commenced supply of Animal Health and Nutrition (AHN) products to one of the world’s largest producers of medicine and vaccines for pets and livestock • Launched an IPO, debuting on the NSE and BSE • Became a Zero-Debt Company • Established the Rossari Centre of Excellence, a certified R&D laboratory at IIT Mumbai, India • Fully commissioned all phases of the greenfield manufacturing facility at Dahej, Gujarat • Tied up with CSIA and Mumbai Airport, to place branded dispensers and supply sanitizers • Expanded into e-commerce by strategically listing HPPC products on Amazon • Incorporated subsidiaries in DMCC, Jafza, Thailand, KSA and Singapore • Commissioned additional 20,000 MTPA Dahej I capacity, across ethylene oxide derivatives • Commissioned 30,000 MTPA Unitop ethoxylation capacity • Joined the UN Global Compact Network India • Acquired ~12.78 acres of land at Dahej GIDC (Bharuch, Gujarat) • Set up of Rossari GRIC, state-of-the- art multi application R&D, at Koparkhairane, Navi Mumbai 1997 – 2004 2024 – 2026 2006 – 2011 2013 – 2019 2020 – 2021 2021 – 2024
Page 16
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials HPPC - Home, Personal Care and Performance Chemicals FY26 Revenue 1,750+ Customers 80+ Geographies 100+ New Products over last 3 years 77% 1,050+ Products Home Care Personal Care Performance Preservatives | Aroma and Fine chemicals | Hygiene | Bath & Body | Skin & Hair care | Sun Care & Photoprotection Soaps & Detergents | Surfactants | Cleaning, Hygiene and Disinfectant Oil & Gas | Agro | Inks, Paints, Coatings | Pulp & Paper | Cement | Water Treatment Pharma Transitioning to value-led partnerships Building regulatory readiness, GMP Compliance & dedicated infrastructure Scale high purity PEGs, esters, pharma coating polymers, and pharma-oriented excipients Oil & Gas Commercialised solutions for upstream and downstream oilfield applications Extends existing asset base into a new end market Address large global market with minimal incremental Capex New Value Added Products 16 Growth Drivers Rising Demand for Surfactants in Home Care and Personal Care Expanding Use in Agrochemicals Shift towards eco-friendly and biodegradable surfactants
Page 17
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials TSC - Textile Specialty Chemicals 17 FY26 Revenue 1,000+ Customers 29+ Geographies 20+ New Products over last 3 years 17% 2,000+ Products Sustainable, bio-based auxiliaries and silicone-based solutions expanding company’s footprint across Bangladesh, Indonesia, Vietnam, Turkey, and Latin America. New blending facility in Thailand serving as a regional technical hub to address the Southeast Asian market Accelerate penetration into large export accounts across Egypt, Southeast Asia, and North Africa Export Led Resilience Capturing the entire value chain, offering true ‘Fibre to Fabric’ solutions for Spin Finishes Silicon based Lubricants Technical Textiles Coatings Enhancing textile performance before spinning and weaving RENEWA Initiative Wax infused lubricants for superior thread and yarn quality Diverse range of coatings for durability and flexibility Introducing green chemistry for sustainable towel processing enzymes, bio-sequestrants, and vegetable oil-based softeners Growth Drivers Growing Fast Fashion Industry and Home Textiles Market Rising Demand for Technical and High- Value Textiles Shift towards sustainable and high-value eco- friendly chemicals
Page 18
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials R&D Centre is at the forefront of developing enzymes, probiotics, herbal products, and non- antibiotic alternatives Aligning with global trends towards healthier food chains Growth driven by replacement of conventional treatments with value-added, high-margin nutritional solutions R&D Led Innovation AHN - Animal Health Nutrition 18 FY26 Revenue 125+ Customers 18+ Geographies 30+ New Products over last 3 years 6% 90+ Products Growth Drivers Evolving into highly specialised life sciences platform Poultry Nutrition Aquaculture Dairy Nutrition Pet Care Growing Global Demand for Poultry Products Advancements in Precision Feeding and Feed Technology Increased Health and Awareness
Page 19
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Key Subsidiaries 19 554 651 774 922 FY23 FY24 FY25 FY26 CAGR 19% Revenue (Rs. crores) 209 253 262 292 FY23 FY24 FY25 FY26 CAGR 12% 79 159 276 251 FY23 FY24 FY25 FY26 CAGR 47% Acquisition Details / Rationale Agreed to acquire 100% equity stake, out of which 80% equity stake is acquired till date for a consideration of Rs. 363 crores To backward integrate into surfactants and emulsifiers To strengthen Agrochemicals and Oilfield chemicals portfolio Cross-selling opportunities across product categories Acquired 100% equity stake for total consideration of Rs. 108 crores To add new international markets, cross-selling opportunities, talent, and technology know-how To expand product portfolio, primarily in personal care segment Expanded distribution network via addition to new channels Description Incorporated in 1980, a leading supplier of Surfactants, Emulsifiers and Specialty chemicals Presence in high-potential Specialty chemical segments, such as Agrochemicals and Oil & Gas segments Operates manufacturing at Dahej and Jammu & Kashmir Integrated manufacturing led to cost saving Incorporated in 1997, a prominent player in the field of Preservatives, Aroma Chemicals, and Home & Personal Care. Preferred supplier to various reputed companies and MNCs across India, Europe, USA and Far East countries High-tech distillation manufacturing facilities at Sarigam, Gujarat Incorporated in 2013 as a JV and then acquired as a wholly owned subsidiary Key emerging player in the Institutional Cleaning Industry Specializes in providing superior cleaning, hygiene and disinfection solutions to various institutions and consumers Acquired 40% equity stake of Buzil for total consideration of Rs. 4.60 crores To strengthen institutional cleaning segment in India by offering high-performance products To deliver advanced cleaning and hygiene solutions across diverse segments Co-developed new products with combined R&D teams Unitop Chemicals Pvt. Ltd. Tristar Intermediates Pvt. Ltd. Buzil Rossari Pvt. Ltd.
Page 20
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Robust Manufacturing Capabilities 20 8 Manufacturing Facilities 4 R&D Centres3,87,100 MTPA Installed Capacity 3,000+ Products State-of-the-art facility, well-equipped with advanced technologies, ensuring precision and scalable production Enjoys proximity to multi-cargo port of Dahej – providing cost & logistical advantage Lean design for resource efficiency and waste reduction Driving cost efficiencies and economies of scale Dahej Plant (I) Dahej Plant (II)1,52,500 MTPA | ~23 Acres Expertise in Ethoxylation, Propoxylation, EO-PO polymers, and blending Expertise in Agrochemicals and Oil & Gas, tailored to industry needs In-house R&D drives innovation, quality, and process standardization Adequate scope for further capacity expansion 90, 000 MTPA | ~22 Acres Silvassa Plant Sarigam Plant Fungible manufacturing capabilities for powders, granules and liquids In-house testing and packaging for quality and efficiency Zero Liquid Discharge and effluent treatment for sustainability 2,500 MT bulk storage capacity for acid, alkali, base oils and surfactants Three units in Sarigam GIDC with strategic industrial benefits Specializes in preservatives, aroma chemicals, and home and personal care additives Advanced distillation and high-quality production 1,20,000 MTPA | ~9 Acres 15,000 MTPA | ~2.5 Acres Other Facilities Thailand Vasai Jammu & Kashmir Bhiwandi
Page 21
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Expanding Global Footprint 21 Map is not to scale. All data, information, and map are provided ‘as is’ without warranty or any representation of accuracy, timeliness or completeness UAE Thailand Vietnam Malaysia Kingdom of Saudi Arabia Bangladesh India Export Countries (2024-25)Offices and Facilities Export Countries Added (2025-26) Thailand Facility: 5,000 MTPA Capacity Kingdom of Saudi Arabia (KSA) • Commissioned a dedicated blending facility in Thailand • Directly address the demand for Textile and HPPC solutions in the region • This operational hub shall reduce turnaround times, and mitigate freight volatility • Offer agile, tailored formulations directly to customers across Southeast Asia • Exploring a greenfield opportunity in a strategically relevant global market • Has set up a wholly owned subsidiary in Kingdom of Saudi Arabia (KSA) • Access to key raw materials, proximity to regional and International demand centres • Alignment with emerging industrial requirements, including specialized opportunities in the Middle East oil & gas sector Transitioning from a domestic specialty chemicals manufacturer into a globally integrated solutions provider, expanding horizons across markets, applications and capabilities. Strengthening access to new markets, better raw materials availability and deeper customer engagement FY26 Revenue Mix 74% Domestic 26% Export
Page 22
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Strong R&D Capabilities: The Foundation of 3,000+ Product Portfolio 22 Rossari’s R&D Priorities Sustainable Chemistry Replacing conventional chemistries with bio-based, biodegradable and safer alternatives Biosurfactants Commercial developments across performance-led applications Process Innovation Shift towards continuous flow processes improving efficiency and product consistency Personal Care Ingredients Expansion into preservatives, blends, emulsifiers, and adjacent cosmetic ingredients Agro and Pharma Applications Developing application-led chemistries supporting customer-specific requirements Textile Innovation Focus on sustainable auxiliaries, spin & fibre finishes, technical textile chemicals, etc. Animal Nutrition Development of enzymes, premixes, probiotics, gut-health solutions and non- antibiotic alternatives Industrial Applications Product development for oil & gas, construction, metal finishing, coatings, etc. ….accelerate the journey from idea to commercial scale ….brings cross functional R&D teams under one roof ….builds a stronger platform for higher value products Integrated research capabilities…. Team Members 45+ R&D Centres 4 70+ New Launches in FY26 Rossari GRIC Global Research and Innovation Centre Integrated R&D facility at Navi Mumbai
Page 23
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Awards, Certifications & Recognitions 23 Industrial Excellence Award FY25 - The Textile Association (India) For sustained contribution to innovation in textile and chemical industry BioSpectrum Excellence Awards 2023 For Best Indian Industrial Enzyme Company for the years 2022 and 2021 Frost and Sullivan Awards 2026 For Eco-efficient textile chemistry technology innovation FICCI Special Jury Award - FY24 For Innovation in Water Technology Golden Peacock Award - FY24 For Innovative Product : Flap-Based Waterless Urinal System Golden Peacock Award (Dr. Nanoxa) - 2022 For innovation in advanced product development PMFAI Company of the Year – Unitop Chemicals - FY24 For outstanding performance - Agrochemical Industry Golden Peacock Award - Business Excellence - 2021 For overall business performance, governance & industry leadership Economic Times Award – Innovation & Sustainability - FY20 For pioneering innovation aligned with sustainability Jamnalal Bajaj Award – Fair Business Practices - 2016 For upholding ethical, transparent, and responsible business conduct Frost and Sullivan Award - 2010 For customer value enhancement in industrial enzymes One Star Export House Award - 2006 By the Government of India Ecovadis Aug 2026 Tristar Intermediate Private Limited Ecovadis Sep 2026 Unitop Chemicals Private Limited
Page 24
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Social Responsibility and Sustainability 24 Education and Community Empowerment To improve access to quality learning, strengthen infrastructure, and promote skill development Various initiatives to address key societal priorities through focused interventions in education, healthcare, human life upliftment, & environmental sustainability. Medical and Healthcare Support Focus on preventive care, access to essential medical services, and support for individuals with special needs Human Life Upliftment and Support Aimed at improving dignity, equality, and empowerment for vulnerable communities Creating long-term positive impact across environment, community, and safety. 1,563 kW installed solar capacity 1,800 trees planted in FY26 306 MT waste recycled Environment & Energy 3 Zero Liquid Discharge facilities 13,772 KLD wastewater treatment ZDHC Level 3 at Dahej I and Thailand 20,000+ lives impacted through CSR initiatives related to education, healthcare, life upliftment and other areas Zero fatalities 72% employee training 3,670 total training hours Water & Waste Management Community & Impact Workplace & Safety
Page 25
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Experienced Promoters and Board of Directors 25 Mr. Sunil Chari Promoter & Managing Director • Over 35 years of experience, including 23 years in the specialty chemicals industry • Central role in shaping the Company’s daily operations and strategic direction, driving its continued growth and innovation in the sector • Honoured by the Victoria Jubilee Technical Institute (VJTI), as a Distinguished Alumnus and also honoured by the Institute of Chemical Technology (formerly UDCT) as an Honorary Alumnus • Bachelor of Arts degree and a Diploma in Technical and Applied Chemistry Mr. Edward Menezes Promoter & Executive Chairman Founders and Promoters Independent Directors Mr. Aseem Dhru • Over 27 years of experience in the banking and financial services sector. His journey features extensive leadership and expertise across retail lending, capital markets, working capital, and small business financing • He is an associate member of the Institute of Chartered Accountants of India and the Institute of Cost and Works Accountants of India • Executive Vice Chairman of SBFC Finance Limited. Previously held senior leadership roles at HDFC Bank & served on the boards of HDB Financial Services and HDFC Securities Ms. Esha Achan • Over 33 years of experience in the field of finance and treasury having held pivotal roles within senior management as a Group President, Global Head leading Global Business, Finance and Treasury operations of MNC’s and publicly listed companies like Glenmark Pharmaceuticals & Bajaj • Master of Business Administration (MBA) in Finance Mr. Gurudas Aras • Over 45 years of experience in the textile industry and was a director of the A.T.E. Group from 1981 until his retirement on 31st March 2021 • He is also on the advisory board and board of Studies of VJTI, Mumbai, and is a member of the advisory editorial board of ‘The Textile Magazine’ and ‘Indian Textile Journal (ITJ)’ • India strategic advisor to ITA Technologie transfer GmbH and APS GmbH, a German company, and is a Business Advisor to Yamuna Machine Works, India Mr. Udeypaul Singh Gill • Over 40 years of experience as an executive and strategist • With a proven track record on the boards of prominent companies, he has made significant contributions towards strategic innovation, carbon neutrality and energy transition • His multifaceted career spans industries such as natural and synthetic fibers, chemicals, fertilizers, banking, textiles, and management consulting • Board member of the International Textile Manufacturers Federation, Vardhman Textiles Limited, Biotexfuture Germany and Fashion for Good, UK • Over 40 years of experience in the specialty chemicals industry, he remains closely involved in the Company’s day-to-day operations • Contributions to the specialty chemicals and textile processing industry recognised with several honours such as the Industrial Excellence Award from The Textile Association (India) (2026), the Hurun India Industry Achievement Award (2022), the All India Industrialist of the Year award from the Federation of Industries of India (2021), and UDCT Distinguished Alumnus Technology Day Award (2013) • B. Sc. (Chemistry) degree, B. Sc. (Technology) degree, and a Master’s Degree in Marketing
Page 26
Key Strategies
Page 27
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Capabilities Built Up For Long-term Growth 27 1,00,000 2,52,500 3,87,100 20,000 1,32,500 64,000 15,000 20,000 15,000 15,000 Silvassa (IPO, FY20) Silvassa Debottleneck Dahej (Mar-21) Standalone FY21 Unitop Acquisition (FY22) Tristar Acquisition (FY22) 600 Vasai Facility Acquisition (Apr-21) Dahej Expansion (Sep-25) Unitop Phase 1 (Sep-25) Unitop Phase 2 (Mar-26) 5,000 Greenfield Thailand Facility (Jun-26) Consolidated FY26 Dahej (in MTPA) • Invested patient capital for long-term value unlocking • Recently invested in sectors like Oil & Gas and Pharma • Long-gestation opportunities requiring sales channel development and regulatory approvals Yet to unlock true potential in medium to long term Dahej Dahej Thailand DahejVasaiSarigam Dahej Silvassa
Page 28
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Key Growth Strategies 28 Deepen customer engagement through cross-sell and solution led offerings Increase wallet share across domestic and MNC accounts Expand into adjacent segments and applications Strong product pipeline across key segments Integrate market insights, consumer understanding and R&D Develop differentiated offerings for evolving customer needs Transitioning into a strategic solutions partner Utilise newly commissioned brownfield capacities in India Evaluate a greenfield facility in KSA to support future growth Improve efficiency and resilience through backward integration and optimisation Expand international distribution across key markets Broaden customer access through a stronger global reach Purse partnerships and selective opportunities to enhance overseas Scale new business lines using existing capabilities and strengths Develop specialty solutions in selected adjacencies Create new avenues to diversify future revenue streams Strengthening manufacturing footprint Innovation & new product development Accelerating growth in core business lines Strengthening international presence Building new growth platforms
Page 29
Q2FY27 Key Highlights Historical Financial Highlights
Page 30
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Consolidated Profit & Loss Statement 30 Particulars (INR in crores) FY26 FY25 FY24 Revenues from Operations 2,396.4 2,080.3 1,830.6 Cost of Goods Sold 1,668.7 1,433.3 1,293.5 Gross Profit 727.6 647.0 537.1 Gross Profit Margin (%) 30.4% 31.1% 29.3% Employee expense 154.7 132.3 103.1 Other expenses 287.0 249.6 184.2 EBITDA 285.9 265.1 249.8 EBITDA Margin (%) 11.9% 12.7% 13.6% Other Income 22.4 4.0 7.4 Depreciation and Amortization 79.1 67.1 60.4 EBIT 229.2 202.0 196.8 EBIT Margin (%) 9.6% 9.7% 10.7% Finance Costs 28.5 17.8 19.4 Share of profit of joint venture and associate 1.9 1.0 0.2 PBT 202.5 185.2 177.6 Tax expense 53.3 48.8 46.9 PAT 149.2 136.4 130.7 PAT Margin (%) 6.2% 6.6% 7.1% EPS Diluted (Rs.) 26.95 24.66 23.67
Page 31
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Consolidated Balance Sheet 31 ASSETS (INR in crores) FY26 FY25 FY24 Non-current Assets 1,045.1 853.0 727.4 Property, plant and equipment 466.5 285.2 260.6 Right of Use Assets 94.0 68.4 54.1 Capital Work-in-progress 173.3 140.2 47.2 Goodwill 118.7 118.7 118.7 Other Intangible Assets 105.2 126.1 144.2 Investments accounted using equity method 27.0 26.3 25.1 Financial Assets (i)Investments 0.2 0.2 0.2 (ii) Other Financial Assets 8.8 7.4 3.4 Income Tax Assets (Net) 12.0 7.7 5.5 Deferred Tax Assets (Net) 14.9 10.5 4.8 Other Non-current Assets 24.4 62.3 63.6 Current Assets 1,235.9 1,041.9 843.6 Inventories 404.5 355.1 282.3 Financial Assets (i)Investments 35.1 57.3 37.6 (ii) Trade Receivables 557.4 474.5 425.1 (iii) Cash and cash Equivalents 75.3 44.2 25.2 (iv) Bank balances other than cash 16.9 13.0 5.0 (v) Loans 1.2 1.2 0.7 (vi) Other Financial Assets 5.9 3.2 4.6 Other Current Assets 139.6 93.4 63.0 Non current assets held for sale 7.8 1.2 1.2 Total Assets 2,288.8 1,896.2 1,572.2 EQUITY & LIABILITIES (INR in crores) FY26 FY25 FY24 Equity 1,333.3 1,185.4 1,047.7 Equity Share Capital 11.1 11.1 11.0 Other Equity 1,322.3 1,174.4 1,036.7 Non-Current Liabilities 165.9 174.2 99.7 Financial Liabilities (i) Borrowings 94.3 100.0 33.3 (ii) Lease Liabilities 20.3 22.3 10.9 Provisions 8.3 5.3 4.0 Deferred Tax Liabilities (Net) 43.0 46.6 51.5 Current Liabilities 789.6 536.6 424.7 Financial Liabilities (i) Borrowings 313.7 87.9 72.5 (ii) Lease Liabilities 7.7 7.7 2.1 (iii) Trade Payables 323.5 286.3 219.1 (iv) Other Financial Liabilities 116.0 114.9 100.7 Other Current Liabilities 11.4 20.1 15.8 Provisions 8.3 7.3 4.5 Current Tax Liabilities (Net) 9.0 12.2 10.1 Total Equity & Liabilities 2,288.8 1,896.2 1,572.2
Page 32
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Key Financial Highlights 32 Export as % of Total Revenue 18% 82% FY22 23% 77% FY23 24% 76% FY24 27% 73% FY25 26% 74% FY26 Export Domestic Profit After Tax 97.7 107.3 130.7 136.4 149.2 FY22 FY23 FY24 FY25 FY26 (INR in crores) Margin Total Revenue 966 1,157 1,369 1,620 1,857 405 373 354 344 400 112 FY22 126 FY23 108 FY24 116 FY25 139 FY26 1,483 1,656 1,831 2,080 2,396 EBITDA 183.4 223.0 249.8 265.1 285.9 FY22 FY23 FY24 FY25 FY26 Gross Profit 377.9 484.6 537.1 647.0 727.6 FY22 FY23 FY24 FY25 FY26 25% 29% 29% 31% 30% 12% 13% 14% 13% 12% AHNHPPC TSC • Figures for previous periods have been reclassified, wherever necessary, to align with the classification adopted for the current period.
Page 33
Key Highlights Financial Highlights Company Overview Growth Levers Historical Financials Consolidated Key Ratios 33 Working Capital Days ROCE (%) ROE (%) Net Debt to Equity (x) 76 79 97 95 97 FY22 FY23 FY24 FY25 FY26-0.09 -0.09 0.04 0.07 0.22 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 24% 21% 21% 17% 15% FY22 FY23 FY24 FY25 FY26 16% 12% 13% 12% 12%
Page 34
Thank You Mr. Sudarshan Dhekane / Ms. Vaamaa Choksi +91 91370 13450 / +91 90222 08577 sudarshan.dhekane@sgapl.net / vaamaa.choksi@sgapl.net Strategic Growth Advisors CIN - U74140MH2010PTC204285 Investor Relations Advisor Mr. Ketan Sablok, Group CFO ketan.sablok@rossari.com Rossari Biotech Limited CIN – L24100MH2009PLC194818 Company 34